Morgan Stanley Maintains Overweight on Seagen, Lowers Price Target to $170

Morgan Stanley analyst Matthew Harrison maintains Seagen (NASDAQ:SGEN) with a Overweight and lowers the price target from $181 to $170.

Morgan Stanley analyst Matthew Harrison maintains Seagen (NASDAQ:SGEN) with a Overweight and lowers the price target from $181 to $170.

Total
0
Shares
Related Posts